Target intelligence / Profile preview

Gut-associated immune cells (GAICs) (GAICs)

Target
GAICs
Molecular classification
Other
01

Overview

Gut-associated immune cells (GAICs) represent a diverse population of leukocytes residing within the gut-associated lymphoid tissue (GALT), including the lamina propria and intestinal epithelium [1.3.1, 1.4.2]. These cells, which include T cells, B cells, macrophages, and dendritic cells, play a critical role in maintaining immune homeostasis by balancing immune tolerance toward commensal microbes and food antigens with robust defense against pathogens [1.1.2, 1.3.3]. In diseases like inflammatory bowel disease (IBD) and food allergies, dysregulation of these cells leads to chronic inflammation and tissue damage [1.1.4, 1.5.1]. Therapeutic strategies often target specific receptors or pathways within these cells, such as the integrin α4β7 to block lymphocyte trafficking or cytokine signaling pathways (e.g., TNF-α, JAK/STAT) to dampen inflammatory responses [1.2.3, 1.3.2]. Additionally, the gut microbiota significantly influences the maturation and function of GAICs through the production of metabolites like short-chain fatty acids (SCFAs), which are being explored for their immunomodulatory potential [1.3.4, 1.4.1].

Other names
GALT cellsIntestinal immune cellsMucosal immune cellsLamina propria lymphocytesIntraepithelial lymphocytesGut-associated lymphoid tissue cells
02

Mechanism of action

Inhibition of lymphocyte trafficking via integrin blockade; Neutralization of pro-inflammatory cytokines (e.g., TNF-alpha, IL-12, IL-23); Inhibition of JAK-STAT signaling; Modulation of immune tolerance via microbial metabolites.

03

Biological functions

Immune responseImmune toleranceMucosal barrier maintenancePathogen defenseCell trafficking
04

Disease associations

Inflammatory bowel diseaseCrohn's diseaseUlcerative colitisFood allergyCeliac diseaseColorectal cancerSystemic inflammation
05

Safety considerations

Increased risk of opportunistic infectionsLoss of mucosal immune tolerancePotential for systemic immunosuppressionGastrointestinal disturbancesRisk of malignancy with long-term immunosuppression
06

Interacting drugs

Vedolizumab

9 more in the full profile.

07

Biomarkers

Fecal calprotectinFecal lactoferrinC-reactive protein (CRP)Interleukin-6 (IL-6)Interleukin-10 (IL-10)Vg4 T cell status

Beyond the preview

Go deeper on Gut-associated immune cells (GAICs) (GAICs).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gut-associated immune cells (GAICs) (GAICs).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call